Dexmedetomidine may be renoprotective by reducing ischemia-reperfusion injury, according to the investigators. Dexmedetomidine may reduce the odds of delayed graft function following ...

Please provide your email address to receive an email when new articles are posted on . At 7 and 42 days postpartum, women who received dexmedetomidine had lower positive postpartum depression rates.

BXCL501 is an oral thin film formulation of dexmedetomidine, a selective alpha-2a receptor agonist. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to BXCL501 ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Dexmedetomidine Injection, USP in ...

Heitor Medeiros, MD, and A. Sassan Sabouri, MD, of the Department of Anesthesia, Critical Care and Pain Medicine at Massachusetts General Hospital, are the lead and corresponding authors, respectively ...